Hambarian, Adam – Trademark Portfolio

Entity Type: 01

Hambarian, Adam holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include OXY TURF, CLEAN LIE, and SMELLS LIKE BIRDIES. The owner is based in Orange, CA.

1401 E. Rose Avenue

Orange, CA 92867

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Hambarian, Adam's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Hambarian, Adam have?

Hambarian, Adam has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.

What trademark classes does Hambarian, Adam file in?

Hambarian, Adam files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Hambarian, Adam's most well-known trademarks?

Hambarian, Adam's registered trademark portfolio includes well-known marks such as OXY TURF, CLEAN LIE, and SMELLS LIKE BIRDIES. These are among 4 currently registered trademarks in the portfolio.

What is Hambarian, Adam's trademark registration success rate?

Hambarian, Adam has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.